5 Views
top of page
The Players Club
Public·9 members
Why Drug Eluting Balloons Are Ideal for Small Vessel Interventions
Small blood vessels present unique challenges. Stents may cause irritation, restrict movement, or fail to conform to narrow anatomy. Drug eluting balloons offer an ideal solution because they deliver medication without leaving anything behind.
These balloons are particularly beneficial in coronary small vessels and distal peripheral branches. The drug coating reduces restenosis risk, while the flexible catheter design enables precise navigation.
Small-vessel DEBs require specialized low-profile designs to avoid damaging delicate vessel walls. Their ability to provide uniform drug penetration ensures high effectiveness even in tight or tortuous areas.
By removing the need for tiny stents, DEBs simplify long-term care and reduce complications that might arise from metal implants.
FAQs
1. Are DEBs safe in fragile vessels?
8 Views
How Oncolytic Virotherapy Targets Metastatic Cancer
Metastatic cancer remains one of the toughest challenges in oncology, but oncolytic virotherapy offers new hope. Unlike localized treatments such as surgery or radiation, viruses have the potential to travel through the bloodstream and reach distant tumor sites.
Once administered—either through intratumoral injections or systemic infusion—oncolytic viruses can circulate and selectively infect metastatic lesions. Their ability to seek out cancer cells is partly due to the defective antiviral defenses commonly found in metastatic tumors. This vulnerability allows the virus to replicate aggressively in distant sites while sparing healthy organs.
One of the powerful aspects of virotherapy is its ability to trigger systemic immune activation. When viruses destroy tumor cells, they expose hidden tumor antigens to the immune system. This widespread immune training can help the body recognize and eliminate cancer cells across multiple tissues, even those not directly infected by the virus.
Scientists are developing viruses with enhanced mobility, better…
2 Views
“Heparin in Oncology: Managing Clot Risks in Cancer Patients”
Individuals undergoing cancer treatment face a higher risk of developing blood clots due to chemotherapy, tumors, and reduced mobility. Heparin has become an essential medication in oncology care because it reduces this risk without interfering with cancer therapies. Oncologists often prescribe Heparin during treatment cycles to maintain safe circulation and support recovery.
Cancer can cause inflammation and vascular changes that make clot formation more likely. Heparin counteracts this process and allows patients to continue treatment without added complications. Its reliability, combined with its ability to be monitored closely, makes it one of the safest anticoagulants for cancer patients.
FAQ
1. Why is Heparin used in cancer treatment?
To reduce clotting risks caused by chemotherapy and tumor pressure.
2. Does Heparin interfere with cancer drugs?
1 View
bottom of page
Advance your career with the College of Contract Management! Whether you want to lead contract management, use your CAD expertise in design, ensure security with NPORS and SMSTS qualifications or build resilience with the Human Firewall program, CCM has the right course for you. Learn at your own pace online from industry experts and get the qualifications you need to excel.